Antiproliferative activity of ester derivatives of monensin A at the C-1 and C-26 positions

Chem Biol Drug Des. 2019 Oct;94(4):1859-1864. doi: 10.1111/cbdd.13581. Epub 2019 Jul 21.

Abstract

Monensin A (MON) is a polyether ionophore antibiotic, which shows a wide spectrum of biological activity, including anticancer activity. A series of structurally diverse monensin esters including its C-1 esters (1-9), C-26-O-acetylated derivatives (10-15), and lactone (16) was synthesized and for the first time evaluated for their antiproliferative activity against four human cancer cell lines with different drug-sensitivity level. All of the MON derivatives exhibited in vitro antiproliferative activity against cancer cells at micromolar concentrations. The majority of the compounds was able to overcome the drug resistance of LoVo/DX and MES-SA/DX5 cell lines. The most active compounds proved to be MON C-26-O-acetylated derivatives (10-15) which exhibited very good resistance index and high selectivity index.

Keywords: antiproliferative activity; drug repurposing; natural products; polyether ionophores.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents* / chemical synthesis
  • Antineoplastic Agents* / chemistry
  • Antineoplastic Agents* / pharmacology
  • Cell Line, Tumor
  • Cell Proliferation / drug effects*
  • Dose-Response Relationship, Drug
  • Humans
  • Monensin* / analogs & derivatives
  • Monensin* / chemical synthesis
  • Monensin* / chemistry
  • Monensin* / pharmacology
  • Neoplasms* / drug therapy
  • Neoplasms* / metabolism
  • Neoplasms* / pathology

Substances

  • Antineoplastic Agents
  • Monensin